We investigated the hibernation effect of epigallocatechin-3-O-gallate (EGCG) on neonatal human tarsal fibroblasts (nHTFs) by analyzing the expression of cell cycle-related genes. EGCG application to culture media moderately inhibited the growth of nHTFs, and the removal of EGCG from culture media led to complete recovery of cell growth. EGCG resulted in a slight decrease in the cell population of the S and G 2 / M phases of cell cycle with concomitant increase in that of the G 0 /G 1 phase, but this cell cycle profile was restored to the initial level after EGCG removal. The expression of cyclin D1 (CCND1), CCNE2, CCNdependent kinase 6 (CDK6), and CDK2 was restored, whereas that of CCNA, CCNB1, and CDK1 was irreversibly attenuated. The expression of a substantial number of genes analyzed by cDNA microarray was affected by EGCG application, and these affected expression levels were restored to the normal levels after EGCG removal. We also found the incorporation of FITC-EGCG into the cytosol of nHTFs and its further nuclear translocation, which might lead to the regulation of the exogenous signals directed to genes for cellular responses including proliferation and cell cycle progression. These results suggest that EGCG temporarily affects not only genes related to the cell cycle but also various other cellular functions.
INTRODUCTION
We hypothesized that this hibernation effect of EGCG on normal cells is partly due to a temporary arrest of the cell cycle. We examined the effects of EGCG Green tea polyphenols are well known as phytochemicals with various bioactivities (16, 27, 32) . Among them, on the expression of cell cycle-related genes and proteins. We used cDNA microarray to examine the influ-(−)-epigallocatechin-3-O-gallate (EGCG), the major polyphenolic constituent of green tea, has anticancer ence of EGCG on the expression levels of human genes, and the data supported the hypothesis. The reversible (19) , antimutagenic (18) , and antimicrobial (31) actions. Recently, EGCG has been reported to have different ef-effect of EGCG on the expression levels of a significant number of genes suggests that there is a potential recov-fects on proliferation between cancer and normal cells, that is, a cytotoxic effect on various cancer cells, but ery of physiological functions and structural elements both essential for tissue and cell preservation. a hibernation effect on normal cells (2). Hyon and his colleagues discovered that EGCG induced cellular hi-MATERIALS AND METHODS bernation with high cell survival rates after preservation (6, 7, 9, 13, 17) . EGCG is thought to increase the survival Cell Culture of normal cells through inhibiting apoptosis by scaveng-Neonatal human tarsal fibroblasts (nHTFs) were obing free radicals harmful to the cells and protecting the tained from a human little toe of a single 1-year-old fragile cell membrane by simply adhering to and reinmale polydactyl patient. After isolated according to esforcing it (1) , but the exact mechanisms have not yet tablished procedures (24), the cells were cultured in Dulbeen fully elucidated.
becco's modified Eagle's medium (DMEM, Sigma, St.
Louis, MO) supplemented with 10% fetal bovine serum incubated with RNase in PBS (20 U/ml, final concentration, Sigma) at 37°C for 30 min. Then, the cells were (Sigma) and a 1% antibiotic antimycotic solution (10,000 U/ml penicillin G, 10 mg/ml streptomycin sul-chilled on ice for 10 min and stained with 100 µg/ml propidium iodide (PI, Sigma) for 1 h. No less than fate, and 25 µg/ml amphotericin B, Sigma) at 37°C in a humidified chamber with 5% CO 2 in air.
10,000 cells were counted through a fluorescence-activated cell sorter (FACSCan TM System, BD Biosciences, EGCG Treatment San Jose, CA), and the data obtained were analyzed using the histogram of CellQuest software on FACScan EGCG was purchased from DSM Nutritional Products Ltd. (Teavigo TM , Basel, Switzerland). To examine (BD Biosciences). the effects of EGCG on the growth and cell cycle of Confocal Laser Scanning Microscopy nHTFs, the cells were seeded on well plates and incubated with 100 µg/ml EGCG. Then, 20 µg/ml catalase To demonstrate whether EGCG was incorporated into the cytosol of nHTFs with further nuclear transloca-(Wako Pure Chemical Industries, Ltd., Osaka, Japan) was added to the EGCG-treated cells to decrease cyto-tion, it was conjugated with fluorescein-4-isothiocyanate (FITC, Dojindo Lab.) by using a modified labeling toxicity induced by H 2 O 2 generating from EGCG (30) . Toxic concentrations of the EGCG and catalase were method (unpublished data). The cells were cultured with 50 µg/ml FITC-conjugated EGCG treatment for 24 h determined from cytotoxicity tests (data not shown). Cells were treated with different methods of EGCG ap-and then washed thoroughly with PBS. After FITC-EGCG treatment, the cells were fixed with 3.5% para-plicaton: in treatment 1 (Tr1), cells were incubated with 100 µg/ml EGCG for 1 day; in treatment 2 (Tr2), cells formaldehyde in 0.1 M phosphate buffer (pH 7) for 5 min at room temperature, and immediately observed un-were incubated with 100 µg/ml for 3 days; in treatment 3 (Tr3), cells were incubated with 100 µg/ml for 9 days; der a confocal laser scanning microscope (LSM 510, Carl Zeiss Advanced Imaging Microscopy, Jena, Ger-in treatment 4 (Tr4), cells were incubated with 100 µg/ ml for 1 day, washed five times with phosphate-buffered many). Cell nuclei were counterstained with 5 µM PI (Sigma) directly before 3-5 min of observation. saline (PBS, pH 7.4), followed by replacement with fresh media and then incubated for additional 2 days; in Western Blotting treatment 5 (Tr5), cells were incubated with 100 µg/ml for 1 day, washed five times with PBS followed by re-After EGCG treatment (Tr1-Tr5), nHTFs were washed twice with cold PBS (10 mM, pH 7.4). Ice-cold placement with fresh media, and then incubated for additional 8 days. As the nontreated control, cells were RIPA lysis buffer (Santa Cruz Biotechnology Inc., Santa Cruz, CA) was added to the cells. After 5 min, the cells incubated without any treatment (Tr0). were scraped, and the lysate was centrifuged at 14,000 Cell Growth Assay × g for 20 min at 4°C. Proteins were extracted from the total lysate, protein concentration was determined by a nHTF (2.0 × 10 3 cells/ml) was seeded on 24-well plates with or without EGCG treatment. EGCG-treated BCA TM protein assay using the manufacturer's protocol (Pierce, Rockford, IL). For immunoblot analysis, 35-40 cells with (Tr1-Tr5) were incubated at 37°C for several time durations. The number of viable cells was quanti-µg of protein was run on 4/20 polyacrylamide-SDS gel (Daiichi Pure Chemicals Co., Ltd., Tokyo, Japan) for 1 fied by an indirect colorimetric method (Cell Counting Kit-8, Dojindo Lab., Kumamoto, Japan), which deter-h at 30 mA and blotted to a PVDF membrane for 50 min at 35 mA. The membrane was blocked in a blocking mines the number of viable cells according to the amount of reduced electron mediators that is propor-buffer (Nacalai Tesque, Inc., Kyoto, Japan) for 1 h at RT and incubated with mouse anti-human cyclin A (CCNA) tional to the degree of cell proliferation (11). Briefly, cells were incubated with a tetrazolium salt for 4 h at monoclonal antibody, mouse anti-human CCNB1 monoclonal antibody, mouse anti-human CCND1 monoclonal 37°C in the dark and washed twice with PBS. The resulting color intensity was measured by a microplate antibody (BD Biosciences), rabbit anti-human CCNE2 monoclonal antibody (Cell Signaling Technology, Inc., reader (VersaMax TM , Molecular Devices Co., Sunnyvale, CA).
Danvers, MA), and, as references, mouse anti-human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Cell Cycle Analysis monoclonal antibody (International Inc., Temecula, CA) or rabbit anti-human β-actin polyclonal antibody (Novus Following EGCG treatment (Tr1-Tr5), nHTFs were trypsinized, collected, and washed with cold PBS (pH Biologicals, Inc., Littleton, CO). The membrane was treated with either an anti-mouse IgG secondary anti-7.2). The cells were resuspended in 95% cold methanol for 1 h at 4°C and then centrifuged at 120 × g for 5 body (Amersham Biosciences, Buckinghamshire, England) or anti-rabbit IgG secondary antibody (Santa min. The pellets were washed twice with cold PBS and Cruz Biotechnology Inc.), HRP conjugated. Protein ex-then automatically washed and stained with a GeneChip Hybridization, Wash and Stain kit (Affymetrix). The pression was detected by a Chemilumi-one chemiluminescent kit (Nacalai Tesque) and detected by an X-ray probe array was scanned using GeneChip operating software (GeneChip Scanner 3000, Affymetrix) and further film (Fujifilm, Tokyo, Japan).
analysis was carried out with GeneSpring GX 7.3.1 Reverse Transcription-Polymerase Chain (Agilent Technologies, Palo Alto, CA). Raw intensity Reaction (RT-PCR) values from each chip were normalized to the 50th percentile of the measurements. Each gene was normalized After EGCG treatment (Tr1-Tr5), total cellular RNA was isolated from nHTFs using an RNeasy Mini kit (Qi-to the median of that gene in the respective control to enable comparison of relative changes in gene expres-agen Inc., Valencia, CA) according to the manufacturer's protocol. The quality of the isolated RNA was eval-sion levels between samples. We standardized the change in gene expression of microarray based on the values for uated by measuring the absorbance ratio of 260 to 280 nm. The RNA was reverse transcribed and amplified the nontreated control, which was adjusted to 1 and those genes that changed over twofold (i.e., either ≥2 or with gene-specific primers using a OneStep RT-PCR Kit (Qiagen). The primer sequences were as follows: 5′-≤1/2). AGCTGCCTTTCATTTAGCACTCTAC-3′ (sense), 5′-Statistical Analysis TTAAGACTTTCCAGGGTATATCCAGTC-3′ (anti-All variables were tested in either four or six replisense) for CCNA2; 5′-CATGGCGCTCCGAGTCA-3′
cates. The results are reported as a mean ± SD, com-(sense), 5′-GCGCCTGCCATGTTGATC-3′ (antisense) pared with the nontreated controls. A one-way analysis for CCNB1; 5′-GAGACCATCCCCCTGACGGC-3′ of variance (ANOVA, SAS Institute Inc., Cary, NC) was (sense), 5′-TCTTCCTCCTCCTCGGCGGC-3′ (antiperformed to analyze the differences in the variables besense) for CCND1; 5′-TGTTGGCCACCTGTATTATC tween the EGCG treatments on nHTFs by a Tukey HSD TGG-3′ (sense), 5′-ATCTGGAGAAATCACTTGTTC test. The value of p < 0.05 was considered statistically CTATTTC-3′ (antisense) for CCNE2; 5′-GAAGGTG significant. AAGGTCGGAGTC-3′ (sense), 5′-GAAGATGGTGAT GGGATTTC-3′ (antisense) for GAPDH; 5′-GTGGGC RESULTS CGCTCTAGGCACCAA-3′ (sense), 5′-CTCTTTGATG Effect of EGCG on Cell Growth TCACGCACGATTTC-3′ (antisense) for β-actin. The Cell growth of EGCG-treated nHTFs was temporarprimers were obtained from Invitrogen (Grand Island, ily inhibited. Cells incubated in the culture medium with NY).
100 µg/ml EGCG (Tr1) stopped proliferation after 1 day of incubation ( Fig. 1 ). The cells that were incubated in cDNA Microarray an EGCG-containing medium (Tr2 and Tr3) remained After EGCG treatment with either Tr1 or Tr4, total almost unproliferating during the incubation period, RNA was isolated and quantified. The isolated RNA while those transferred to a fresh medium to remove was amplified and labeled according to the method de-EGCG (Tr4) resumed cell growth after 5 days. The cell scribed in the GeneChip Expression Analysis Technical proliferation was significantly (p < 0.05) suppressed Manual (Affymetrix, Santa Clara, CA). Total RNA (1 when EGCG was added in the culture medium. After 8 µg) was converted into double-stranded cDNA using a days of EGCG removal (Tr5), the proliferation resumed, One-Cycle cDNA Synthesis kit (Affymetrix). Doubleand the proliferating speed reached initial levels. Treatstranded cDNA was purified by using a GeneChip Samment of EGCG for 1 day (Tr1) retained cellular proliferple Cleanup Module (Affymetrix). In vitro transcription ation over 60% compared with the nontreated control. reactions were performed using a GeneChip IVT Label-Cellular proliferation was rapidly resumed after the reing kit (Affymetrix), which includes T7 RNA polymermoval of EGCG and restored to the levels of the control ase and biotin-labeled ribonucleotides. Biotin-labeled [i.e., 71% after 2 days of EGCG removal (Tr4), 99% cRNA was then purified using a GeneChip Sample after 8 days (Tr5)]. When cells were continually incu-Cleanup Module. The concentration of cRNA was calbated with EGCG for 9 days (Tr3), cellular proliferation culated from light absorbance at 260 nm using a UV was suppressed down to 8% of the control. Compared spectrophotometer (UV-1600PC, Shimadzu, Kyoto, Jato the number of cells upon initial seeding, those of the pan). cRNA (15 µg) was fragmented at 94°C in the prescontrol cells and cells treated for 1 day and then reence of a fragmentation buffer (Affymetrix). Fifteen mimoved of EGCG increased exponentially. crograms of the cRNA was hybridized to a GeneChip Effect of EGCG on Cell Cycle Human Genome U133 Plus2.0 array (Affymetrix) containing oligonucleotide probe sets representing 54,675
Cytometric analysis showed that EGCG treatment of nHTFs changed the profile of their DNA contents ( 2). The cell cycle of the cells treated with EGCG for 1 sponse to FITC-EGCG and its binding pattern to receptors would be different from those of EGCG, it was day (Tr1) was significantly (p < 0.05) arrested at G 0 /G 1 phase (G 0 /G 1 : 92.6%, S: 4.3%, and G 2 /M: 3.1%) com-found with adsorption onto the membrane as well as distribution into the cytosol (Fig. 3A) . At higher magnifica-pared to that of the nontreated control (Tr0, G 0 /G 1 : 65.1%, S: 11.0%, and G 2 /M: 23.9%). In these cells that tion, it was clearly seen onto the membrane as well as widely distributed into both the cytosol and nucleus of were continually exposed to EGCG (Tr2 and Tr3), the cell cycle did not recover. This EGCG treatment resulted the cells particularly with intensively bright green fluorescence after 24 h (Fig. 3B) . These results imply that in significant (p < 0.05) increase of the cell population at G 0 /G 1 phase with concomitant decrease at S and G 2 / EGCG can be incorporated into the cytosol of the cells through binding to specific receptors and forming com-M phases (Tr2; G 0 /G 1 : 93.6%, S: 2.9%, and G 2 /M: 3.5%, Tr3; G 0 /G 1 : 90.2%, S: 6.6%, and G 2 /M: 3.2%). In Tr4, plexes with them and further be translocated into the nucleus, which contributes to the reversible regulation the cell population at S phase completely recovered after 2 days of EGCG removal from the culture media, but of the cell cycle and subsequent hibernation. that at G 2 /M phase was maintained at a low level (G 0 / Effect of EGCG on Expression of CCN Proteins G 1 : 80.5%, S: 12.6%, and G 2 /M: 6.9%). After 8 days of and RNAs EGCG removal (Tr5), the proportion of cells at G 2 /M Figure 4 demonstrates the regulating effects of phase was restored to the level of control cells (G 0 /G 1 :
EGCG on the expression level of CCN proteins in 70.7%, S: 11.7%, and G 2 /M: 17.6%).
nHTFs. The protein expression levels of CCND1, Cellular Uptake of FITC-EGCG in nHTFs CCNE2, and CCNB1, which regulate the G 1 phase, G 1 / S phase transition, and M phase, respectively, decreased To determine the incorporation of EGCG into the cyby EGCG treatment (Tr1), but they were restored after tosol of nHTFs and its further nuclear translocation, flu-2 days of EGCG removal (Tr4). The expression level of orescence microscopy was performed in the cells treated CCNA, which mainly regulate the G 2 /M phase transiwith 50 µg/ml FITC-EGCG. Although the cellular re-tion, was similarly decreased after EGCG treatment and that received a present call, which is statistically reliable with respect to the control. Among them, the expression remained at low levels even 2 days after the removal of EGCG. These results were in agreement with those of levels of 3,142 genes (16.2%) were changed over twofold by EGCG treatment relative to control signals. the cell cycle profile, showing that the cell cycle of EGCG-treated cells for 1 day was arrested at G 0 /G 1 Among these genes, the expressions of 1,894 genes (60.3%) were restored to the original levels, but for the phase and it was restored after EGCG removal.
As shown in Figure 5 , the data of RT-PCR analysis rest of the 1,248 genes (39.7%) their expression was not restored even 2 days after the removal of EGCG. largely correlated with the immunoblotting data of the expression level of CCN proteins with the exception of We categorized genes according to various functions: cellular (36.9%), physiological (35.0%), regulatory CCNA. The RNA expression of representative CCNs was suppressed by the treatment of EGCG, but upon (13.4%), developmental (5.9%), signal transduction (5.7%) processes, and the others (3.0%). Cellular pro-its removal their expression levels were restored. The expression of CCND1 and CCNE2 was slightly de-cesses represent cell cycle and apoptosis. Among 151 cell cycle-related genes, the expression levels of 33 creased by EGCG treatment, but the level was restored to that of the control after its removal. Contrastingly, the genes (31.4%) were changed due to EGCG treatment. Within these 33 genes, the expression of 20 genes expression of CCNA2 and CCNB1 was strongly decreased by EGCG treatment, but was not fully recovered (60.6%) returned to the initial levels, and the rest [i.e., 13 genes (39.4%)] did not even after EGCG removal. 2 days after the removal of EGCG.
Among the 251 genes related to apoptotic process, the Effect of EGCG on Whole Gene Expression expression of 31 genes (12.4%) was changed over twofold with EGCG treatment. Among them, the expression We employed a cDNA microarray analysis to evaluate the effect of EGCG on the expression level of the of 20 genes (64.5%) was restored after 2 days of EGCG removal, but that of 11 genes (35.5%) was not within 2 whole human genome. The genechip containing 54,675 human genes was used and included 151 cell cycle-days. In 455 genes correlated with immune response, the expression of 34 genes (7.5%) was changed with EGCG related genes. We report here only the difference in gene expression levels that are statically significant. Out of treatment. Among these genes, that of 17 genes (50.0%) was restored, but the rest was not after the removal of 54,675 probe sets, we focused on 19,434 (35.5%) genes 
EGCG. Detailed expression of cell cycle-related genes
biological activities of EGCG, we previously examined cytopreservative effects on mammalian cells and tissues is listed in Tables 1 and 2. Most CCNs were strongly downregulated with EGCG treatment (Tr1), particularly to design a cell-or tissue-preserving medium at physiological temperature (4,8,10). In this study, we hypothe-CCNA2 (Tr1) and CCNB1 (Table 1 ). After removal of EGCG (Tr4), however, the expressions of CCNA2 and sized that EGCG would temporarily suppress the expression of cell cycle-related genes in the normal cells. The CCNB1 as well as CCN-dependent kinase 1 (CDK1) were not completely restored to the control levels. In cell cycle-related genes were suppressed during the period when the cells were kept in a medium containing contrast, the expression levels of CCND1 and CCNE2 were relatively less suppressed, but those of CCND1 and EGCG, but once EGCG was removed from the medium, the gene expression was restored to the original levels. CCNE2 as well as CDK6 and CDK2 were restored to near normal levels after EGCG removal. Moreover, the This reversible cell cycle regulation showed a temporal correlation with the results in the cell growth assay ( Fig.  expression of some kinds of CDK inhibitors, 1A, 1C, 2B and 2D, was appreciably upregulated with EGCG 1). The cell cycle profiles of EGCG-treated cells also showed the increase of G 0 /G 1 phase and the suppression treatment, and this upregulation was maintained after EGCG removal. Interestingly, other CDKs and CDK in-of S and G 2 /M phases, indicating that EGCG arrests the ongoing cell cycle at G 1 phase and prevents nuclear rep-hibitors were not affected by EGCG treatment (Table 2) . lication (Fig. 2) . Removal of EGCG from the culture DISCUSSION medium restored the profile of DNA contents similar to the one before EGCG treatment or the control, which In this study, we found that EGCG has a hibernationinducing effect on nHFTs and that the induction of and suggests that the effect of EGCG on cell cycle is reversible. recovery from the hibernation are correlated with a reversible regulation of the cell cycle. Among the various
The cellular uptake of FITC-EGCG treated to nHTFs was clearly observed (Fig. 3) . However, the incorpora-DNA binding, both groups seemed to hold strands of DNA via their branching structure (14). tion of FITC-EGCG into cells was appreciably decreased by pretreatment of free EGCG (data not shown), Generally, cDNA microarray analysis provides extensive information on global gene expression. Indeed, the suggesting that a negligible amount of conjugate will accumulate within cells by virtue of competition with data presented here demonstrated the global regulation of multiple genes involved in cell cycle, apoptosis, and unlabeled EGCG for membrane binding sites. These results suggest that although the cellular sensitivity and immune response that are considered as some of the most important factors for cell or tissue preservation. response to EGCG would be different from those of FITC-EGCG, it might incorporate into the cytoplasm of Those genes that changed over twofold (i.e., either ≥2 or ≤1/2) constituted 16.2% of the entire genes examined. cells through binding to specific receptors onto the membrane and forming complexes with the receptors, As we had predicted, over 60% of such changed were reversed 2 days after EGCG removal. Based on the re-and further be translocated into the nucleus. These phenomena could be related to the intrinsic characteristics sults of cell growth assay and cytometry, it is predicted that the expression of most genes that were changed of the polyphenolic compound, EGCG. EGCG is amphipathic and easily binds to extracellular matrices, lipid over twofold with EGCG treatment can be restored to the initial levels after 8 days of EGCG removal. There-membranes, or any types of intracellular proteins (15, 22, 28) . Therefore, it seems that EGCG can be incorporated fore, the reversible hibernation effects of EGCG may allow its safe usage on cell and tissue preservation for into cell cytosol and further translocated into a nucleus and may modulate the exogenous signals directed to transplantation (20) due to the recovery of physiological and/or structural dysfunctions of treated cells and tis-genes required for the survival and apoptosis of cells. Although exact mechanism of the incorporation of sues. Our findings from cDNA microarray showed that EGCG into cells had not been elucidated, some evidence was reported that EGCG was bound to the membrane as 31.4% cell cycle-related genes were strongly affected by EGCG treatment. Among cell cycle-related genes, those well as incorporated into the cytosol and the nucleus of cancer cell lines, such as PC-9 and HT-29 cells (5,21). that were the most affected by EGCG treatment were CCNs (Table 1) . Indeed, CCNs are directly involved in Recent studies have demonstrated that expression of the metastasis-associated 67-kDa laminin receptor might cell cycle regulation. Interestingly, there was substantial difference in the response to EGCG even among the cell confer EGCG responsiveness to cancer cells at physiologically relevant concentrations, suggesting that the cycle-related genes, CCNs and CDKs. For examples, CCNA2, CCNB1, and CDK1, essential for M phase and gallate moiety of EGCG may be critical for receptor binding and subsequent activity (26, 29) . Moreover, the G 2 /M phase transition, were strongly suppressed under 1/10 levels, but not completely recovered to the original observation that nucleic acids extracted from catechintreated cells were colored implied that because both gal-levels. In contrast, CCND1 and CCNE2 as well as CDK6 and CDK2, essential for G 1 phase and G 1 /S phase loyl and catechol groups of EGCG were essential for
